Cerebral ischemia-reperfusion injury (CI/RI) is a complex pathological process that often
occurs secondary to trauma, surgery, and shock. Peroxisome proliferator activated receptor …

Cerebral ischemic injury is a leading cause of death and long-term disability throughout the
world. Peroxisome proliferator-activated receptor gamma (PPAR-ɣ) is a ligand-activated …

Traumatic brain injury (TBI) represents a major health care problem and a significant
socioeconomic challenge worldwide. No specific therapy for TBI is available. The …

Peroxisome proliferator-activated receptor gamma (PPARγ) has been implicated in the
pathology of numerous diseases involving diabetes, stroke, cancer, or obesity. It is …

Peroxisome proliferator‐activated receptor gamma (PPAR‐γ) is a nuclear membrane‐
associated transcription factor that governs the expression of various inflammatory genes …

Peroxisome proliferator-activated receptor γ (PPARγ) is a widely expressed ligand-
modulated transcription factor that governs the expression of genes involved in …

Ischemic stroke is a leading cause of death and disability worldwide. Currently, the only
pharmacological therapy for ischemic stroke is thrombolysis with tissue plasminogen …

Peroxisome proliferator-activated receptor γ (PPARγ) has been shown to protect against
stroke and improve neurological outcome after cerebral ischemia. This study investigated …

Ischemia-reperfusion injury (IRI) is a complex pathophysiological process that is often
characterized as a blood circulation disorder caused due to various factors (such as …

Stroke is a devastating disease with limited treatment options. Recently, we found that the
peroxisome proliferator‐activated receptor‐γ (PPARγ) agonists troglitazone and …